Literature DB >> 15642390

Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.

Barbara Pienkowska-Grela1, Anna Witkowska, Beata Grygalewicz, Grzegorz Rymkiewicz, Jolanta Rygier, Renata Woroniecka, Jan Walewski.   

Abstract

Translocations involving chromosome 8 are the most common aberrations in B-cell non-Hodgkin lymphoma (B-NHL). The presence of the typical t(8;14)(q24;q32) or its variants has been confirmed in all cases of Burkitt lymphoma (BL), in some cases of Burkitt-like lymphoma (BLL), and in diffuse large B-cell lymphoma (DLBCL). The alterations lead to deregulated expression of c-myc protein by a chromosomal translocation joining C-MYC gene with sequences from immunoglobulin (Ig) enhancers. The C-MYC gene rearrangement plays an essential role in leukemogenesis of BL and probably plays a part in other aggressive NHLs. The present study was undertaken to compare the cytogenetic features in cases of BL, BLL, and DLBCL. We detected chromosomal aberrations by G-banding and fluorescence in situ hybridization (FISH) painting in 10 cases of aggressive B-NHL and used FISH to visualize the C-MYC gene rearrangement. Chromosome 8 was most frequently involved in structural aberrations (8/10 cases), and 4 cases showed the typical t(8;14)(q24;q32). Only two of 5 patients suspected of having BL fulfilled all the criteria for this diagnosis; in the others, chromosome 8 was aberrant, but the absence of C-MYC rearrangement or the results of flow cytometry excluded the diagnosis of BL. All BLL cases showed C-MYC overexpression, but only one had a rearrangement of the C-MYC gene; the remaining cases showed other aberrations of chromosome 8. This study indicates that the mechanisms of C-MYC activation involved in BLL can be different from that for the BL.

Entities:  

Mesh:

Year:  2005        PMID: 15642390     DOI: 10.1016/j.cancergencyto.2004.04.009

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.

Authors:  Christopher J Stasik; Hiroaki Nitta; Wenjun Zhang; Charles H Mosher; James R Cook; Raymond R Tubbs; Joseph M Unger; Tracy A Brooks; Daniel O Persky; Sarah T Wilkinson; Thomas M Grogan; Lisa M Rimsza
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.

Authors:  Michalina Zajdel; Grzegorz Rymkiewicz; Magdalena Chechlinska; Katarzyna Blachnio; Barbara Pienkowska-Grela; Beata Grygalewicz; Krzysztof Goryca; Maria Cieslikowska; Zbigniew Bystydzienski; Pawel Swoboda; Jan Walewski; Jan Konrad Siwicki
Journal:  Tumour Biol       Date:  2015-02-13

3.  Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma.

Authors:  Itziar Salaverria; Andreas Zettl; Silvia Beà; Elena M Hartmann; Sandeep S Dave; George W Wright; Evert-Jan Boerma; Philip M Kluin; German Ott; Wing C Chan; Dennis D Weisenburger; Armando Lopez-Guillermo; Randy D Gascoyne; Jan Delabie; Lisa M Rimsza; Rita M Braziel; Elaine S Jaffe; Louis M Staudt; Hans Konrad Müller-Hermelink; Elias Campo; Andreas Rosenwald
Journal:  Haematologica       Date:  2008-08-12       Impact factor: 9.941

4.  A strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphoma.

Authors:  Lisa M Rimsza; Joseph M Unger; Margaret E Tome; Michael L Leblanc
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

5.  Oral Burkitt's lymphoma--case report.

Authors:  Roseana de Almeida Freitas; Simone Souza Lobão Veras Barros; Lêda Bezerra Quinderé
Journal:  Braz J Otorhinolaryngol       Date:  2008 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.